Heterogeneity of anti-Caspr2 antibodies: specificity and pathogenicity.
Su J, Gupta R, Van Hoof S, Kreye J, Prüss H, Spielman B, Brimberg L, Volpe BT, Huerta PT, Diamond B.
Su J, et al.
bioRxiv [Preprint]. 2025 Jan 21:2025.01.16.633238. doi: 10.1101/2025.01.16.633238.
bioRxiv. 2025.
PMID: 39896527
Free PMC article.
Preprint.